Moxifloxacin
موکسیفلوکساسین
🦠 Antiinfectives For Systemic UseFluoroquinolone
Market / country: 🇺🇸 USA
Avelox (US)
🧮 Dose calculator
Community-acquired pneumonia · Regimen source: FDA Moxifloxacin · 2.1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to moxifloxacin or any quinolone. FDA Moxifloxacin · 4
- ⛔ Effectiveness under 18 not established. FDA Moxifloxacin · 8.4
Warnings
- • Fluoroquinolone boxed warning: tendon rupture, peripheral neuropathy, CNS effects, myasthenia exacerbation; for sinusitis/bronchitis only if no alternative. FDA Moxifloxacin · Boxed Warning
Important interactions
- • Take 4 h before or 8 h after magnesium, aluminium, iron, zinc, antacids or multivitamins. FDA Moxifloxacin · 2.2
Formulations
- 400 mg tablet — tablet 🇺🇸 USA FDA Moxifloxacin · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Moxifloxacin · 8.1
“Based on animal studies with moxifloxacin, moxifloxacin hydrochloride may cause fetal harm.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Moxifloxacin · 8.2
“Risk Summary It is not known if moxifloxacin is present in human milk.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Moxifloxacin · 8.4
“Effectiveness in pediatric patients and adolescents less than 18 years of age has not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Moxifloxacin · 8.5
“Caution should be used when prescribing moxifloxacin hydrochloride to elderly patients especially those on corticosteroids.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA202632
- DailyMed (FDA label)FDA Moxifloxacin
- MedlinePlus (NIH)MoxifloxacinMoxifloxacin Injection
- WHO ATC/DDDJ01MA14
- Darooyab (Iran)Moxifloxacin
🇮🇷 Registered in Iran Darooyab · G-444/Moxifloxacin
Dosage forms with Iranian generic codes, per Darooyab.
- 14266 · MOXIFLOXACIN 0.5% 5ML OPH DROP · قطره چشمی موکسیفلوکساسین ۰٫۵ درصد ۵ میلیلیتر
- 08277 · MOXIFLOXACIN HCL 400MG TAB · قرص موکسیفلوکساسین هیدروکلراید ۴۰۰ میلیگرم
- 52529 · MOXIFLOXACIN SOLUTION, DROPS OPHTHALMIC 0.5 % 0.5 mL · قطره چشمی موکسیفلوکساسین ۰٫۵ درصد ۰٫۵ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Moxifloxacin · 3FDA Moxifloxacin · 2.1FDA Moxifloxacin · 4FDA Moxifloxacin · 8.4FDA Moxifloxacin · Boxed WarningFDA Moxifloxacin · 2.2FDA Moxifloxacin · 8.1FDA Moxifloxacin · 8.2FDA Moxifloxacin · 8.5FDA Moxifloxacin · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-444/Moxifloxacin
- Clinical review⚠ Unverified